pause use of the Johnson Johnson COVID-19 vaccine after “extremely rare” reports of blood clots in people who get the vaccine.
The Food and Drug Administration and the Centers for Disease Control and Prevention are investigating six cases involving vaccinated women who developed blood clots, called cerebral venous sinus thrombosis (CVST), in combination with low levels of blood platelets.
The women were between the ages of 18 and 48 and experienced symptoms six to 13 days after vaccination. One woman died, and another remains in critical condition, federal health officials said.
CVST is a rare and severe type of blood clot that forms in the brain’s venous sinuses and prevents blood from draining out of the brain, according to Cedars Sinai Medical Center in Los Angeles.
FDA, CDC recommend pausing use of Johnson Johnson vaccine after reports of rare but severe blood clotsdropped about 2% in afternoon trading as investors assessed how the pause would affect the company’s vaccine rollout. Conversely, shares of two other COVID-19 vaccine makers, Moderna and Pfizer’s partner, BioNTech, rallied Tuesday.
Other travel companies also saw shares drop as investors assessed how the vaccine news might affect the pace of recovery from the coronavirus pandemic. Shares of American Airlines, Delta Air Lines and a mix of retailers and hotels all dropped.
Contributing: Elizabeth Weise and Adrianna Rodriguez; the Associated Press
Check back for updates
Article source: http://rssfeeds.usatoday.com/~/649055262/0/usatoday-newstopstories~What-do-I-do-if-Ive-gotten-the-Johnson-Johnson-COVID-shot-Your-questions-answered/